When Dolly was born on July 5, 1996, the world reacted with a mixture of fascination and fear. Many imagined that the cloning of living beings would pave the way for armies of human clones, mass-produced animals, and a complete revolution in the reproduction of life; however, time revealed that the greatest discovery was not the mere possibility of copying organisms, but the realization that an adult cell could turn back the clock.
It all began with a technique known as somatic cell nuclear transfer. Researchers extracted the nucleus from an adult mammary gland cell of a sheep and inserted it into an egg cell from which the genetic material had been removed; an electric pulse then tricked the egg into "believing" it had been fertilized, triggering the development of a new embryo.
Since the DNA originated from the adult cell, the resulting animal possessed virtually the same genetic material as the donor sheep. While it seemed simple in theory, it was incredibly difficult in practice; producing Dolly required 277 attempts, as the vast majority of the embryos simply ceased to develop. The problem was never copying the DNA; the true challenge lay in convincing an adult cell to completely shed its existing identity.
A skin cell, for example, carries exactly the same DNA as a brain cell; what differs are the small chemical markers that determine which genes remain switched on or off—a set of instructions known as epigenetics. When this reset occurs incompletely, the cell continues to behave like a specialized cell, and the embryo fails to develop normally. It was precisely while trying to understand this mechanism that science made a leap far greater than cloning itself.
Years later, researchers discovered that it was possible to reprogram adult cells without creating an entire embryo; thus, induced pluripotent stem cells—known as iPS cells—were born. By using just a few regulatory proteins, an ordinary skin cell can revert to an embryonic-like state, becoming capable of giving rise to virtually any tissue in the body. Today, these cells are used in laboratories worldwide to study diseases, test drugs, and develop future regenerative therapies, thereby reducing the need to use embryos in many areas of research.
Meanwhile, cloning also found applications quite different from those envisioned in the 1990s. In elite livestock breeding, genetically valuable animals can be cloned to preserve rare traits; in environmental conservation, scientists have succeeded in bringing back individuals of threatened species using genetic material frozen for decades—as was the case with the black-footed ferret in the United States.
At the same time, de-extinction projects began to take a different path. Instead of directly cloning extinct species, researchers used tools like CRISPR to edit the DNA of living species, inserting genetic traits lost over the course of history; this is precisely the strategy being explored in projects involving the woolly mammoth and the Asian elephant. Thirty years later, Dolly remains one of the most important experiments in the history of biology—not because it ushered in the era of clones, but because it demonstrated something far more profound: that a cell's identity is not fixed. Today, we know that the code of life can be reprogrammed, corrected, and in some cases, even rejuvenated; perhaps Dolly’s true legacy was never about copying life, but rather showing that we can learn to rewrite it.
